EcoHealth’s Peter Daszak deletes tweet revealing Wuhan lab researchers at Fauci-funded conference
By News Editors // Sep 03, 2021

Posted on December 10th, 2019, just weeks before the Chinese government reported its first case of COVID-19, the tweet revealed Daszak’s attendance at the Nipah Virus International Conference in Singapore.

Brighteon.TV

(Article by Natalie Winters republished from TheNationalPulse.com)

“The two-day session was co-hosted by Duke-NUS Medical School (Duke-NUS) and the Coalition for Epidemic Preparedness Innovations (CEPI). Also listed as organizers are the World Health Organization and the National Institute of Allergy and Infectious Diseases,” reports the site Some Bitch Told Me. CEPI was founded with a sizable investment from the Bill & Melinda Gates Foundation.

In the now-deleted tweet, Daszak details how Shi Zhengli, the Wuhan Institute of Virology’s “bat lady,” calls for “open and transparent international scientific collaboration on pandemic risk pathogens” at her lab’s Biosafety Level 4 (BSL-4) facility. He follows up with a slide explaining how “you can train in the BSL-4 lab in Wuhan.”

NOW-DELETED TWEET.

Read more at: TheNationalPulse.com and Outbreak.news



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.